EFFECTS OF CA-2+ ANTAGONISTS NIFEDIPINE AND DILTIAZEM ON ISOLATED HUMAN CHORIONIC ARTERIES AND VEINS

被引:10
作者
REVIRIEGO, J
FERNANDEZALFONSO, MS
GUERRA, P
MARIN, J
机构
[1] UNIV AUTONOMA MADRID,FAC MED,DEPT FARMACOL & TERAPEUT,C ARZOBISPO MORCILLO 4,E-28029 MADRID,SPAIN
[2] UNIV EXTREMADURA,FAC MED,DEPT FARMACOL & TERAPEUT,BADAJOZ,SPAIN
关键词
!sup]45[!/sup]Ca[!sup]2+[!/sup] uptake; Ca[!sup]2+[!/sup] antagonists; Human chorionic vessels; Potassium; Serotonin;
D O I
10.1097/00005344-199007000-00018
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
5-Hydroxytryptamine (5-HT) and K+ induced contractions in human chorionic arteries and veins. 5-HT-caused responses were blocked by ketanserin (10-7 and 10-6 M) and prazosin (10-5 but not 10-6 M). K+-induced contractions were practically abolished in a Ca2+-free medium, whereas those produced by 5-HT were reduced. The efficacy (EC50 values) of diltiazem to produce relaxation in arteries and veins contracted with 40 or 75 mM K+ was similar, but normally greater than that of nifedipine. The potency of nifedipine (IC50 values) to inhibit maximal K+ contractions was greater than to inhibit maximal 5-HT contractions; diltiazem showed an inverse order of potency, which was less than that of nifedipine. The time course of 10-6 M 5-HT and 75 mM K+ contractions was different, as much in the absence as in the presence of both Ca2+ antagonists; 5-HT contractions were transient, but sustained those elicited by K+. K+ (75 mM) and 5-HT (10-6 M) produced increases in 45Ca2+ uptake, which were reduced by the Ca2+ antagonists. These results indicate that (a) human chorionic arteries and veins are similarly sensitive to Ca2+ antagonists, (b) 5-HT-induced contractions were largely dependent on extracellular Ca2+ and mainly mediated by 5-HT2 receptors but not by α1-adrenoceptors, and (c) nifedipine was more potent than diltiazem in inhibiting Ca2+ influx through potential- and receptor-dependent Ca2+ channels.
引用
收藏
页码:128 / 138
页数:11
相关论文
共 45 条
[1]   EFFECTS OF VASOACTIVE AGENTS ON ISOLATED HUMAN UMBILICAL ARTERIES AND VEINS [J].
ALTURA, BM ;
ORKIN, LR ;
REICH, CF ;
MALAVIYA, D .
AMERICAN JOURNAL OF PHYSIOLOGY, 1972, 222 (02) :345-&
[2]  
ARNEKLONOBIN B, 1985, J CARDIOVASC PHARM, V7, pS52
[3]   CALCIUM REGULATION IN VASCULAR SMOOTH-MUSCLE - IS THERE A PATTERN TO ITS VARIABILITY WITHIN THE ARTERIAL TREE [J].
BEVAN, JA ;
BEVAN, RD ;
HWA, JJ ;
OWEN, MP ;
TAYO, FM .
JOURNAL OF CARDIOVASCULAR PHARMACOLOGY, 1986, 8 :S71-S75
[4]  
BHARGAVA I, 1970, ACTA ANAT, V75, P13
[5]   MECHANISMS OF ACTION OF TRANSMITTERS AND OTHER SUBSTANCES ON SMOOTH-MUSCLE [J].
BOLTON, TB .
PHYSIOLOGICAL REVIEWS, 1979, 59 (03) :606-718
[6]   ACTIONS OF SEROTONIN ANTAGONISTS ON DOG CORONARY-ARTERY [J].
BRAZENOR, RM ;
ANGUS, JA .
EUROPEAN JOURNAL OF PHARMACOLOGY, 1982, 81 (04) :569-576
[7]   ENDOTHELIAL CELL MORPHOLOGY IN FOCAL AREAS OF INVIVO EVANS-BLUE UPTAKE IN YOUNG PIG AORTA .1. QUANTITATIVE LIGHT MICROSCOPIC FINDINGS [J].
CAPLAN, BA ;
GERRITY, RG ;
SCHWARTZ, CJ .
EXPERIMENTAL AND MOLECULAR PATHOLOGY, 1974, 21 (01) :102-117
[8]   MECHANISMS OF CALCIUM ANTAGONIST-INDUCED VASODILATION [J].
CAUVIN, C ;
LOUTZENHISER, R ;
VANBREEMEN, C .
ANNUAL REVIEW OF PHARMACOLOGY AND TOXICOLOGY, 1983, 23 :373-396
[9]   DILTIAZEM - A REVIEW OF ITS PHARMACOLOGICAL PROPERTIES AND THERAPEUTIC EFFICACY [J].
CHAFFMAN, M ;
BROGDEN, RN .
DRUGS, 1985, 29 (05) :387-454
[10]  
COHEN ML, 1986, J PHARMACOL EXP THER, V238, P860